Go to deals
Healthcare

Adventum has been acquired by Humana

Humana, a leading Swedish provider of personal assistance services, has acquired Adventum, a specialized care provider offering support and care for children with social and psychiatric problems. Financial terms of this transaction have not been disclosed.

Humana is focused on elderly care, individual and family care, residential arrangements offering support and services for persons with certain functional impairments, as well as schools for students with disabilities.

This acquisition is an important step for Humana in developing its business unit Individual and Family that includes Baggium Care and Treatment, Tian Group and K REHAB. Adventum is a fast-growing, high quality company in an exciting market that is in the initial consolidation phase.

Oaklins' team in Sweden advised the seller in this transaction.

Parties

Talk to the deal team

Adel Koubaa

Managing Partner
Stockholm, Sweden
Oaklins Sweden

Related deals

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Healthcare

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval

Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.

Learn more
Rare Patient Voice has been acquired by Konovo
Healthcare | TMT

Rare Patient Voice has been acquired by Konovo

Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.

Learn more
Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
Healthcare

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.

Learn more